Kulik LM, Fisher RA, Rodrigo DR, Brown RS JR Jr., Freise CE, Shaked A, et al
Retatrutide: early evidence on its effects on weight loss, lean mass, and muscle function, as well as the limitations of the data being collected in ongoing clinical trials [48:00]
Since starting GLP-1 injections, my appetite is way down, and I actually feel full after meals
Despite the development of new medications and therapeutic approaches, such as phosphodiesterase inhibitors and sphingosine receptor modulators, only approximately 40% of patients achieve clinical remission after one year, highlighting the need for new treatment modalities [320322]
As the GLP1 market evolves and potentially lowercost options emerge, employers who adopt measured, datadriven approaches today will be best positioned to adapt their benefits strategy.